Cargando…
13.4 % Efficiency from All‐Small‐Molecule Organic Solar Cells Based on a Crystalline Donor with Chlorine and Trialkylsilyl Substitutions
How to simultaneously achieve both high open‐circuit voltage (V (oc)) and high short‐circuit current density (J (sc)) is a big challenge for realising high power conversion efficiency (PCE) in all‐small‐molecule organic solar cells (all‐SM OSCs). Herein, a novel small molecule (SM)‐donor, namely FYS...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518815/ https://www.ncbi.nlm.nih.gov/pubmed/34057293 http://dx.doi.org/10.1002/cssc.202100860 |
Sumario: | How to simultaneously achieve both high open‐circuit voltage (V (oc)) and high short‐circuit current density (J (sc)) is a big challenge for realising high power conversion efficiency (PCE) in all‐small‐molecule organic solar cells (all‐SM OSCs). Herein, a novel small molecule (SM)‐donor, namely FYSM−SiCl, with trialkylsilyl and chlorine substitutions was designed and synthesized. Compared to the original SM‐donor FYSM−H, FYSM−Si with trialkylsilyl substitution showed a decreased crystallinity and lower highest occupied molecular orbital (HOMO) level, while FYSM−SiCl had an improved crystallinity, more ordered packing arrangement, significantly lower HOMO level, and predominant “face‐on” orientation. Matched with a SM‐acceptor Y6, the FYSM−SiCl‐based all‐SM OSCs exhibited both high V (oc) of 0.85 V and high J (sc) of 23.7 mA cm(−2), which is rare for all‐SM OSCs and could be attributed to the low HOMO level of FYSM−SiCl donor and the delicate balance between high crystallinity and suitable blend morphology. As a result, FYSM−SiCl achieved a high PCE of 13.4 % in all‐SM OSCs, which was much higher than those of the FYSM−H‐ (10.9 %) and FYSM−Si‐based devices (12.2 %). This work demonstrated a promising method for the design of efficient SM‐donors by a side‐chain engineering strategy via the introduction of trialkylsilyl and chlorine substitutions. |
---|